PRESS RELEASES

To view each press releases, please click the corresponding PDF button.

Announces 2015 Annual Results

2016. 6. 13

Officially Launches New Version of Its Corporate Website and IR WeChat Platform

2016. 6. 3

Completes Phase I Single Ascending Dose (SAD) Tolerability Study of Uni-EPO-Fc for Treatment of Anaemia

2016. 3. 7

Garners Prize at Hong Kong Business High Flyers Awards

2016. 1. 20

Acquires Global Rights to Type 2 Diabetes Drug Mitiglinide from Jiangsu Hansoh Pharmaceutical Co. Ltd

2015. 11. 24